Ursodeoxycholic Acid Market Trends, Growth, Demand, opportunities, Scope & Forecast 2023 by CMI



 Ursodeoxycholic acid, commonly known as ursodiol, is a kind of deoxycholic acid (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was discovered in a black bear's bile for the first time. Ursodeoxycholic acid is an essential clinical medication used to treat gallstones, cholecystitis, PBC, and PSC with a large market. Ursodeoxycholic acid was previously synthesized using a standard organic synthesis method.

Ursodeoxycholic acid is a liver disease treatment. Ursodeoxycholic acid has a beneficial effect on liver disease treatment. Synthetic Ursodeoxycholic Acid and Extraction Ursodeoxycholic Acid is two types of Ursodeoxycholic Acid. In 2017, Synthetic Ursodeoxycholic Acid made up about 73.4 percent of the total, whereas Extraction Ursodeoxycholic Acid made up around 26.57 percent.

The Ursodeoxycholic Acid Market is expected to grow at a 10.4 percent CAGR in revenue over the following five years, reaching US$ 960 million by 2023, up from US$ 530 million in 2017. The global ursodeoxycholic acid market size was valued at US$ 457.3 million in 2017 and is expected to exhibit a CAGR of 10.1% over the forecast period (2018 – 2026).

Ursodeoxycholic Acid is used in pharmaceuticals and health care products. Ursodeoxycholic Acid is most commonly used in health products, with a market share of approximately 69.2% in 2017.With a consumption market share of over 47 percent in 2017, Asia-Pacific is the largest consumer region. With a consumption market share of 26.6 percent in 2017, Europe is the second-largest consumption region after Asia-Pacific.

The majority of China's output is destined for export. Asia is the primary consumer market. The two largest consumer countries are Japan and South Korea. Ursodeoxycholic acid is mostly employed in the Asian healthcare business for traditional reasons.

In 2017, Europe was the leading supplier of Ursodeoxycholic Acid, with a production revenue market share of over 41% and a sales market share of 26.4 percent. That is to say, Europe has a diverse range of exports. Asia is also the leading supplier of Ursodeoxycholic Acid, with a market share of approximately 42 percent in production income and 47 percent in sales in 2017.

Dipharma Francis Srl, ERREGIERRE S.p.A., Grindeks, Industria Chimica Emiliana, Mitsubishi Tanabe Pharma Corporation, Zhongshan Belling Biotechnology Co., Glenmark Pharmaceutical Limited, Arbil Chempharma Private Limited, Biotavia Labs Pvt Ltd, Daewoong Bio Inc., PharmaZell GmbH, and Suzhou Tianlu Bio-pharmaceutical Co., Ltd. are among the major players in the global Ursodeoxycholic acid market.

Comments

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area